FDA: Imaging, not aspirate tests, is the way to screen for breast cancer

12/19/2013 | Plain Dealer (Cleveland), The

Patients and clinicians should be aware that nipple aspirate tests do not deliver on common claims that suggest they are a good mammogram alternative, according to the FDA. "The key thing is that there really is only one exam whose value has been identified and supported by large, population-based clinical trials -- mammography," said Dr. Michael McNamara. "We use [ultrasound and biopsy] as an adjunct."

View Full Article in:

Plain Dealer (Cleveland), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA